Full Text View
Tabular View
No Study Results Posted
Related Studies
Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Dose Response
This study has been completed.
Study NCT00640250   Information provided by Allerderm

First Received on March 3, 2008.   Last Updated on February 19, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Contact Dermatitis
Additional conditions recognized in this trial
Dermatitis
Dermatitis, Contact
More general conditions related to this trial
Skin Diseases
Skin Diseases, Eczematous
Additional drug interventions recognized in this trial
Bronopol
More general drug interventions related to this trial
Anti-Infective Agents
Anti-Infective Agents, Local
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Allerderm


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services